Sensorion SA (ALSEN.PA)

EUR 0.64

(-6.16%)

Total Assets Summary of Sensorion SA

  • Sensorion SA's latest annual total assets in 2023 was 46.49 Million EUR , up 19.43% from previous year.
  • Sensorion SA's latest quarterly total assets in 2024 Q2 was 101.52 Million EUR , down 0.0% from previous quarter.
  • Sensorion SA reported annual total assets of 38.93 Million EUR in 2022, down -34.03% from previous year.
  • Sensorion SA reported annual total assets of 59.01 Million EUR in 2021, down -13.05% from previous year.
  • Sensorion SA reported quarterly total assets of 46.49 Million EUR for 2023 Q4, down 0.0% from previous quarter.
  • Sensorion SA reported quarterly total assets of 27.52 Million EUR for 2023 Q2, down 0.0% from previous quarter.

Annual Total Assets Chart of Sensorion SA (2023 - 2011)

Historical Annual Total Assets of Sensorion SA (2023 - 2011)

Year Total Assets Total Assets Growth
2023 46.49 Million EUR 19.43%
2022 38.93 Million EUR -34.03%
2021 59.01 Million EUR -13.05%
2020 67.87 Million EUR 78.17%
2019 38.09 Million EUR 302.37%
2018 9.46 Million EUR -15.18%
2017 11.16 Million EUR -5.83%
2016 11.85 Million EUR -28.26%
2015 16.51 Million EUR 653.59%
2014 2.19 Million EUR 93.56%
2013 1.13 Million EUR 199.04%
2012 378.71 Thousand EUR 24.98%
2011 303.01 Thousand EUR 0.0%

Peer Total Assets Comparison of Sensorion SA

Name Total Assets Total Assets Difference
ABIONYX Pharma SA 14.71 Million EUR -216.071%
ABIVAX Société Anonyme 327.06 Million EUR 85.784%
Adocia SA 24.95 Million EUR -86.304%
Aelis Farma SA 26.28 Million EUR -76.911%
Biophytis S.A. 11.93 Million EUR -289.528%
Advicenne S.A. 12.4 Million EUR -274.741%
genOway Société anonyme 31.84 Million EUR -46.013%
IntegraGen SA 8 Million EUR -481.15%
Medesis Pharma S.A. 1.92 Million EUR -2313.603%
Neovacs S.A. 47.53 Million EUR 2.187%
NFL Biosciences SA 3.97 Million EUR -1070.95%
Plant Advanced Technologies SA 14.91 Million EUR -211.77%
Quantum Genomics Société Anonyme 3.74 Million EUR -1140.911%
Theranexus Société Anonyme 7.23 Million EUR -542.384%
TME Pharma N.V. 2.49 Million EUR -1766.482%
Valbiotis SA 33.24 Million EUR -39.84%
TheraVet SA 7.53 Million EUR -517.108%
Valerio Therapeutics Société anonyme 35.27 Million EUR -31.808%
argenx SE 4.11 Billion EUR 98.869%
BioSenic S.A. 9.55 Million EUR -386.391%
Celyad Oncology SA 16.28 Million EUR -185.555%
DBV Technologies S.A. 165.65 Million USD 71.932%
Galapagos NV 4.35 Billion EUR 98.933%
Genfit S.A. 173.87 Million EUR 73.26%
GeNeuro SA 6.31 Million EUR -636.493%
Hyloris Pharmaceuticals SA 47.68 Million EUR 2.489%
Innate Pharma S.A. 184.19 Million EUR 74.758%
Inventiva S.A. 69.13 Million EUR 32.753%
MaaT Pharma SA 42.93 Million EUR -8.3%
MedinCell S.A. 36.94 Million EUR -25.837%
Nanobiotix S.A. 93.89 Million EUR 50.484%
Onward Medical N.V. 43.62 Million EUR -6.567%
Oryzon Genomics S.A. 106.9 Million EUR 56.507%
OSE Immunotherapeutics SA 81.9 Million EUR 43.231%
Oxurion NV 6.55 Million EUR -609.833%
Pharming Group N.V. 426.33 Million EUR 89.095%
Poxel S.A. 4.82 Million EUR -864.007%
GenSight Biologics S.A. 9.08 Million EUR -411.655%
Transgene SA 45.21 Million EUR -2.824%
Financière de Tubize SA 1.92 Billion EUR 97.579%
UCB SA 15.53 Billion EUR 99.701%
Valneva SE 469.39 Million EUR 90.095%
Vivoryon Therapeutics N.V. 30.82 Million EUR -50.813%